Skip to main content
Clinical Trials/NCT06261372
NCT06261372
Completed
Not Applicable

The Influence of Mindfulness Meditation Combined With Progressive Muscle Relaxation Training on the Clinical Efficacy and Quality of Life of Hemodialysis Patients With Sarcopenia

Ningbo Medical Center Lihuili Hospital1 site in 1 country49 target enrollmentAugust 15, 2023

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Hemodialysis Patients With Sarcopenia
Sponsor
Ningbo Medical Center Lihuili Hospital
Enrollment
49
Locations
1
Primary Endpoint
KDQOLTM(Kidney Disease Quality of Life short Form) score
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

To study the effect of mindfulness meditation combined with progressive muscle relaxation training on clinical efficacy and quality of life in maintenance hemodialysis (MHD) patients with sarcopenia. Eligible sarcopenic patients in our hospital were randomly assigned to a control group (n = 24) and an intervention group (n = 25). The control group received conventional dialysis treatment, while the intervention group received mindfulness meditation combined with progressive muscle relaxation training during the interdialysis period in addition to conventional dialysis treatment. The effect of the intervention was evaluated after 12 weeks.To observe whether the combined intervention training can improve the motor ability and quality of life of patients with sarcopenia in a short period of time.

Registry
clinicaltrials.gov
Start Date
August 15, 2023
End Date
November 15, 2023
Last Updated
2 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Ningbo Medical Center Lihuili Hospital
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Patients who met the sarcopenia criteria established by the Asian Working Group for Sarcopenia (AWGS) in 2014
  • Stable condition and generally good health status
  • Good compliance and ability to collaborate well with the physician
  • Undergoing hemodialysis three times per week for at least three months, with a KT/V ≥ 1.2
  • No significant cardiovascular or cerebrovascular complications (such as severe heart failure, severe arrhythmias, angina, and cerebrovascular diseases)
  • Patients with sarcopenia who met the clinical diagnostic criteria were selected to ensure the quality of the included patients

Exclusion Criteria

  • Inability to complete handgrip strength, 6-meter walk test, 10 sit-to-stand tests, and the use of bioelectrical impedance analysis (BIA) due to contraindications
  • Coexistence of mental illness or severe cognitive or communication disorders

Outcomes

Primary Outcomes

KDQOLTM(Kidney Disease Quality of Life short Form) score

Time Frame: 3 months

The KDQOLTM score is between 0 and 100, and the higher the score, the better the health

high-sensitivity C-reactive protein (hsCRP)

Time Frame: 3 months

hsCRP represents an inflammatory marker, and its concentration ranges from 0.0 to 10mg/L.

albumin(ALB)

Time Frame: 3 months

Albumin represents a nutritional indicator, and its concentration ranges from 40 to 55g/L.

10 sit-to-stand test in seconds

Time Frame: 3 months

The 10 sit-stand test represents exercise ability, and the shorter the time, the greater the exercise ability.

interleukin-6 (IL-6)

Time Frame: 3 months

Interleukin 6 represents an inflammatory marker, and its concentration is 20pg/ml or less.

prealbumin (PA)

Time Frame: 3 months

Prealbumin represents a nutritional indicator, and its concentration ranges from 0.20 to 0.43g/l.

Grip strength in kilograms

Time Frame: 3 months

Grip strength represents exercise ability, and the larger it is, the more exercise ability it is.Its minimum value is zero, and its maximum value is unlimited.

6-meter walk test in metre per second

Time Frame: 3 months

6-meter walk test represents exercise ability, and the larger it is, the more exercise ability it is.Its minimum value is zero metre per second, and its maximum value is unlimited.

Study Sites (1)

Loading locations...

Similar Trials